We are pleased to announce that James C. Blair, Ph.D., and Patrick J. Geraghty have been appointed to our Board of Trustees.
James Blair, of Princeton, N.J., and San Diego, Calif., is a partner with Domain Associates, founded in 1985 to invest exclusively in emerging life sciences companies. He has been involved at the board level in the creation and successful development of more than 40 life sciences ventures including Amgen, Amylin Pharmaceuticals, Applied Biosystems, NuVasive, Pharmion, and Volcano.
Patrick Geraghty of Ponte Vedra Beach, Fla., is chairman and chief executive officer of Florida Blue, the state’s largest health plan serving more than seven million people across the state. He serves as a board member for a variety of organizations, including the National Institute of Health Care Management and Prime Therapeutics. He is a member of the Florida Council of 100, which advises the governor on key Florida issues from a business perspective.
Kristiina Vuori, M.D., Ph.D., Sanford-Burnham’s president and interim CEO, said, “In seeking trustees we look for business acumen and a strong understanding of the potential impact of our research. We have found both of these characteristics in James Blair and Patrick Geraghty. Each gentleman can provide insight from his industry that affords us an invaluable perspective. We are very fortunate to add their expertise to our already robust board.”